Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate panel limits new drugmaker restrictions on 340B safety-net providers, adopts compromise
Summary
The Senate Finance, Ways and Means Committee approved Senate Bill 1414 after adopting a compromise amendment that preserves existing pharmaceutical audit and data requests through June 1 but bars new restrictions after July 1. Sponsors said the change protects contract pharmacies and rural access while retaining federal and AG oversight.
The Senate Finance, Ways and Means Committee on April 8 approved Senate Bill 1414, a measure aimed at curbing certain restrictions pharmaceutical manufacturers place on 340B covered entities and their contract pharmacies.
Supporters said the bill is a negotiated compromise that preserves current audit and data practices in the short term but prevents new manufacturer-imposed limits that could reduce patient access through contract pharmacies. Sen. Brent Briggs, the bill sponsor, told the committee the measure “will prevent [manufacturers] from interfering with or restricting safety-net providers' contract pharmacy arrangements, including limiting access to these pharmacies.”
The bill follows months of controversy over whether…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
